Pharmacologic Augmentation of TMS for Depression With D-serine
NCT: NCT06876129 · RECRUITING
광고
NCT IDNCT06876129
상태RECRUITING
시작일2025-04-01
완료2027-04-01
SponsorMclean Hospital (OTHER)
First posted
Last updated
간략 요약
The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.